Methods for treating the premenstrual or late luteal phase syndrome

Patent 4971998 Issued on November 20, 1990. Estimated Expiration Date:

September 15, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Aryloxyphenylpropylamines in treating depression
Patent #: 4018895
Issued on: 04/19/1977
Inventor: Molloy , et al.

Composition and method for suppressing appetite for calories as carbohydrates
Patent #: 4210637
Issued on: 07/01/1980
Inventor: Wurtman , et al.

d-Fenfluramine for modifying feeding behavior
Patent #: 4309445
Issued on: 01/05/1982
Inventor: Wurtman , et al.

Arloxyphenylpropylamines
Patent #: 4314081
Issued on: 02/02/1982
Inventor: Molloy , et al.

Method of utilizing d,l-fenfluramine for modifying feeding behavior
Patent #: 4452815
Issued on: 06/05/1984
Inventor: Wurtman , et al.

Anti-anxiety method
Patent #: 4590213
Issued on: 05/20/1986
Inventor: Stark

Method for treating depression with d-fenfluramine Patent #: 4649161
Issued on: 03/10/1987
Inventor: Wurtman , et al.

Inventors

Application

No. 244944 filed on 09/15/1988

US Classes:

514/654The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only

Examiners

Primary: Friedman, Stanley J.

Attorney, Agent or Firm

Hamilton, Brook, Smith & Reynolds

Foreign Patent References

0123469 EP. 10/13/1984
0253146 EP. 06/13/1987
2129299A GB. 06/13/1982

International Class

A61K 031/135

Abstract

Compositions useful in the treatment of disturbances of appetite, disturbances of mood, or both, associated with premenstrual syndrome, as well as methods of use therefor. The compositions include serotoninergic drugs, such as d-fenfluramine and fluoxetine.

Other References

Wurtman, J. et al., International Journal of Eating Disorders, vol. 4, No. 1, 789-99 (1985)
O'Rourke, D. et al., In: Annals of the New York Academy of Sciences, Wurtman, R. J. and J. J. Wurtman (Ed.) 449:329-330 (1987)
Lieberman, H. R. et al., American Journal of Clinical Nutrition, 44:772-778 (1986)
D. R. Rubinow and P. Roy-Byrne, The American Journal of Psychiatry, 141:163-172 (1984)
P. M. S. O'Brien, Drugs, 24:140-151 (1982)
A. J. Rapkin et al., Obstetrics and Gynecology, 70(4):533-537 (1987)
J. J. Wurtman, Journal of Clinical Psychiatry, 49(8):37-39 (1988)
Vaatstra, W. J. et al., Eur. J. Pharmacol., 70:195-202 (1981)
Waldmeier, P. C. et al., Eur. J. Pharmacol., 46:387-391 (1977)
Waldmeier, P. C. and Delini-Stula, A. A., Eur. J. Pharmacol., 55:363-373 (1979)
Waldmeier, P. C. Eur. J. Pharmacol., 60:315-322 (1979)
Diggory, G. L. et al., Arch. Int. Pharmacodynam., 248:86-104 (1980)
James, T. A. and Starr, M. S., J. Pharm. Pharmacol., 32:196-200 (1980)
Blundell, J. E. and Latham, J. C., In: Central Mechanism of Anoretic Drugs, S. Garattini and R. Samanin, Eds., pp. 83-109, Raven Press, NY (1977)
Samanin, R. et al., Prog. Neuro-Psychopharmacol., 4:363-369 (1980)
Benfield, P. et al., Drugs, 32(6):481-508 (1986)
Moses, P. L. and Wurtman, R. J., Life Sciences, 35:1297-1300 (1984)
Kim, S. and Wurtman, R. J., Physiology & Behavior, 42:319-322 (1977